R&D Podcasts | pharmaphorum

Podcasts

R&D

Sandoz’s Pierre Bourdage on biosimilars: the pharmaphorum po...

In the latest episode of the podcast Dominic Tyer speaks with Pierre Bourdage, who’s global head of biopharmaceuticals at Sandoz about the big issues in biosimilars.

R&D

Novartis’ Amit Nastik on COVID’s supply chain impact: the ph...

Episode 41 of the pharmaphorum podcast heard from Amit Nastik about the impact of COVID-19 on pharma supply chains and how he and his team mitigated disruption to Novartis’ own operations.<

R&D

Kantar Health's Biotech Insights podcast with Genmab

Biotech Insight podcast: Overcoming planning challenges in o...

The first episode of Kantar Health’s new Biotech Insight podcast takes aim at the planning and forecasting challenges that biotechnology companies face, with a particular focus on oncology.

R&D

Organicell on regenerative medicine: the pharmaphorum podcas...

In the latest episode of the podcast Dominic Tyer speaks with Dr Maria Ines ‘Mari’ Mitrani, chief science officer at the clinical-stage biopharmaceutical company Organicell Regenerativ

R&D

Pharmacy and clinical research: the pharmaphorum podcast

In the latest episode of the pharmaphorum podcast, pharmaphorum’s web editor Catherine Longworth speaks to Gerald Finken, the founder and CEO of RxE2.

R&D

Roche on COVID-19 healthcare and testing: the pharmaphorum p...

For episode 30 I spoke with Dr Ashton Harper, who’s head of medical affairs in the UK and Ireland at Roche Diagnostics, about the pressure COVID-19 has put on healthcare systems.